Recombinant enterovirus 71 vaccine (Biokangtai)

重组肠道病毒71型疫苗（深圳康泰生物）

Report date: 2024/06/01 20:00:05

Base Information

Drug NameRecombinant enterovirus 71 vaccine (Biokangtai)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHand, Foot and Mouth Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaPending

Originator CompaniesShenzhen Kangtai Biological Products Co Ltd Beijing Minhai Biotechnology Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A

Inactive CompaniesBeijing Minhai Biotechnology Co Ltd Shenzhen Kangtai Biological Products Co Ltd

Active IndicationsN/A

Inactive IndicationsHand, Foot and Mouth Disease

Other Information

ATC CodeN/A